tiprankstipranks
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY
US Market
Want to see SONVY full AI Analyst Report?

Sonova Holding AG (SONVY) Earnings Dates, Call Summary & Reports

31 Followers

Earnings Data

Report Date
Nov 24, 2026
Before Open (Confirmed)
Period Ending
2027 (Q2)
Consensus EPS Forecast
1.11
Last Year’s EPS
0.9
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q4 2026
Earnings Call Date:May 18, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlights strong product-led sales momentum (notably in wholesale and select APAC markets), meaningful operating leverage, high cash conversion and disciplined capital allocation. Key short-term challenges are concentrated in the Cochlear Implants business (notably China) and several non‑core one-off charges plus FX headwinds. Management provided a confident but execution‑sensitive midterm roadmap (innovation, multi-channel expansion, operational savings) and reiterated growth and margin guidance for FY26/27.
Company Guidance
Sonova guided FY 2026/27 to consolidated sales growth of 5–8% and core EBIT growth of 7–10% at constant exchange rates, assuming market growth of about 2–4% this year (trending toward a mid‑term 3–5% range); they expect wholesale to outpace the market, retail to deliver robust organic growth plus ~1–2% contribution from M&A and accelerated store openings, and Cochlear Implants to face H1 headwinds with a meaningful H2 pickup after a planned new processor launch. Management flagged modelling items: non‑core items of CHF 35–40m, M&A contribution to group sales ~1–2%, and FX as of early May 2026 that would reduce reported Swiss‑franc sales growth by ~1–2 percentage points and core EBIT growth in CHF by ~2–3 percentage points; H1 is expected to lie within the 7–10% core EBIT growth range.
Strong Hearing Instruments Growth and Margin Expansion
Hearing Instruments segment sales rose 7.5% to CHF 3.4bn with growth accelerating to 7.9% in H2. Normalized EBITDA for the segment increased 17.3% to CHF 794m, delivering a 23.7% margin (up ~280 basis points in local currencies).
Wholesale Momentum and Product-led Share Gains
Wholesale revenue increased 9.5% to CHF 1.9bn (H2 growth 10.9%). Successful launches (Infinio Ultra, Virto R) drove the highest year-on-year market share gain since the Marvel platform; Virto R reached a recurring revenue run-rate of ~CHF 120m p.a. from zero.
Retail Expansion and Stable Organic Growth
Retail revenues grew 5.1% to CHF 1.5bn (bolt-on acquisitions contributed ~1.3 percentage points). Store network expansion (Germany, Austria, Canada) and retail lead-generation investments supported sequential Q4 momentum.
Innovation and Operational Differentiators
New AI-enabled products (Sphere, Ultra) and innovations like Virto R (first rechargeable in-ear device for Phonak) and EasyGuard (wax-management reducing service time ~38%) reinforce product leadership and addressability.
Profitability, Cash Generation and Capital Efficiency
Group operating leverage led to normalized EBITA/EBIT improvements (normalized EBITA rose ~17.3%). EPS grew 16%. Cash conversion remained strong (>90%), ROCE at 19%, and leverage improved with net debt/EBITDA at ~1.1x (down from 1.2x).
Disciplined Capital Allocation and Shareholder Returns
Board proposed a 7% dividend increase to CHF 4.70 per share (~45% payout ratio). M&A bolt-ons were small (CHF 46m) and management expects M&A to contribute ~1–2% to group growth depending on timing.
Clear and Credible Outlook
Management guided FY26/27 consolidated sales growth of 5–8% and core EBIT growth of 7–10% at constant exchange rates, with market growth assumption of 2–4% for the year (gradually moving toward 3–5% midterm).
APAC Opportunity and Early Traction
APAC (excluding Cochlear Implants) delivered >8% growth; Japan showed very strong recent momentum (management cited 30–45% growth in recent months in that market), supporting the multi-year Asia expansion plan.

Sonova Holding AG (SONVY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SONVY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 24, 2026
2027 (Q2)
1.11 / -
0.897
May 18, 2026
2026 (Q4)
1.44 / 1.44
1.706-15.65% (-0.27)
Nov 14, 2025
2026 (Q2)
0.98 / 0.90
0.8485.78% (+0.05)
May 09, 2025
2025 (Q4)
1.36 / 1.71
1.28932.35% (+0.42)
Nov 19, 2024
2025 (Q2)
0.87 / 0.85
0.984-13.82% (-0.14)
May 14, 2024
2024 (Q4)
1.17 / 1.29
1.299-0.77% (-0.01)
Nov 21, 2023
2024 (Q2)
0.93 / 0.98
1.036-5.02% (-0.05)
May 16, 2023
2023 (Q4)
1.24 / 1.30
1.10617.45% (+0.19)
Nov 14, 2022
2023 (Q2)
0.96 / 1.04
1.054-1.71% (-0.02)
May 17, 2022
2022 (Q4)
0.63 / 1.11
1.277-13.39% (-0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SONVY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 18, 2026
$45.55$49.17+7.94%
Nov 14, 2025
$55.05$51.10-7.17%
May 09, 2025
$60.68$62.60+3.17%
Nov 19, 2024
$70.83$67.43-4.81%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sonova Holding AG Unsponsored ADR (SONVY) report earnings?
Sonova Holding AG Unsponsored ADR (SONVY) is schdueled to report earning on Nov 24, 2026, Before Open (Confirmed).
    What is Sonova Holding AG Unsponsored ADR (SONVY) earnings time?
    Sonova Holding AG Unsponsored ADR (SONVY) earnings time is at Nov 24, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SONVY EPS forecast?
          SONVY EPS forecast for the fiscal quarter 2027 (Q2) is 1.11.